Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Maria Paragliola

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|December 6, 2024
Asymptomatic Hypocalcemia Related to Denosumab Administration in Bone-Metastatic Patient Affected by Colorectal Cancer: A Case ReportAndrea Corsello, Francesco Torino, Annapina De Rosa, et al.
Expert Opinion on Drug Discovery|October 27, 2021
Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancerPietro Locantore, Roberto Novizio, Andrea Corsello, et al.
Biomedicines|December 2, 2020
Medical Approaches in Adrenocortical CarcinomaRosa Maria Paragliola, Andrea Corsello, Pietro Locantore, et al.
Hormones (Athens, Greece)|April 22, 2021
The ancient Greek poet Sappho and the first case report of the fight-or-flight responseGiampaolo Papi, Valentina Cuomo, Enrico Tedeschini, et al.
Expert Opinion on Drug Discovery|October 15, 2019
Lenvatinib for thyroid cancer treatment: discovery, pre-clinical development and clinical applicationRosa Maria Paragliola, Andrea Corsello, Valeria Del Gatto, et al.
Case Reports in Endocrinology|June 2, 2018
46,XY Disorder of Sex Development Caused by 17<i>α</i>-Hydroxylase/17,20-Lyase Deficiency due to Homozygous Mutation of <i>CYP17A1</i> Gene: Consequences of Late DiagnosisGiampaolo Papi, Rosa Maria Paragliola, Paola Concolino, et al.
Frontiers in Endocrinology|March 19, 2019
Factors Predicting Time to TSH Normalization and Persistence of TSH Suppression After Total Thyroidectomy for Graves' DiseaseRosa Maria Paragliola, Vincenzo Di Donna, Pietro Locantore, et al.
Endocrine|May 4, 2017
Is levothyroxine requirement the same for tablet and soft gel formulations?Vincenzo Di Donna, Rosa Maria Paragliola, Chiara de Waure, et al.
Drug Design, Development and Therapy|November 9, 2016
Clinical utility of lanreotide Autogel<sup>®</sup> in gastroenteropancreatic neuroendocrine tumorsRosa Maria Paragliola, Alessandro Prete, Giampaolo Papi, et al.
Endocrine|April 3, 2020
Effect of vitamin D supplementation on TSH levels in euthyroid subjects with autoimmune thyroiditisAlice Villa, Andrea Corsello, Marco Cintoni, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Endocrine, Metabolic & Immune Disorders Drug Targets|December 6, 2024
Asymptomatic Hypocalcemia Related to Denosumab Administration in Bone-Metastatic Patient Affected by Colorectal Cancer: A Case ReportAndrea Corsello, Francesco Torino, Annapina De Rosa, et al.
Expert Opinion on Drug Discovery|October 27, 2021
Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancerPietro Locantore, Roberto Novizio, Andrea Corsello, et al.
Biomedicines|December 2, 2020
Medical Approaches in Adrenocortical CarcinomaRosa Maria Paragliola, Andrea Corsello, Pietro Locantore, et al.
Hormones (Athens, Greece)|April 22, 2021
The ancient Greek poet Sappho and the first case report of the fight-or-flight responseGiampaolo Papi, Valentina Cuomo, Enrico Tedeschini, et al.
Expert Opinion on Drug Discovery|October 15, 2019
Lenvatinib for thyroid cancer treatment: discovery, pre-clinical development and clinical applicationRosa Maria Paragliola, Andrea Corsello, Valeria Del Gatto, et al.
Case Reports in Endocrinology|June 2, 2018
46,XY Disorder of Sex Development Caused by 17<i>α</i>-Hydroxylase/17,20-Lyase Deficiency due to Homozygous Mutation of <i>CYP17A1</i> Gene: Consequences of Late DiagnosisGiampaolo Papi, Rosa Maria Paragliola, Paola Concolino, et al.
Frontiers in Endocrinology|March 19, 2019
Factors Predicting Time to TSH Normalization and Persistence of TSH Suppression After Total Thyroidectomy for Graves' DiseaseRosa Maria Paragliola, Vincenzo Di Donna, Pietro Locantore, et al.
Endocrine|May 4, 2017
Is levothyroxine requirement the same for tablet and soft gel formulations?Vincenzo Di Donna, Rosa Maria Paragliola, Chiara de Waure, et al.
Drug Design, Development and Therapy|November 9, 2016
Clinical utility of lanreotide Autogel<sup>®</sup> in gastroenteropancreatic neuroendocrine tumorsRosa Maria Paragliola, Alessandro Prete, Giampaolo Papi, et al.
Endocrine|April 3, 2020
Effect of vitamin D supplementation on TSH levels in euthyroid subjects with autoimmune thyroiditisAlice Villa, Andrea Corsello, Marco Cintoni, et al.
Pageof 8